机构

• 烟台海岸带研究所 [2]
• 上海药物研究所 [1]
• 大连化学物理研究所 [1]
• 心理研究所 [1]
• 合肥物质科学研究院 [1]

采集方式

• OAI收割 [6]

内容类型

• 期刊论文 [6]

发表日期

• 2024 [1]
• 2023 [1]
• 2021 [1]
• 2020 [1]
• 2015 [1]

学科主题

筛选

浏览/检索结果: 共6条，第1-6条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择题名升序题名降序提交时间升序提交时间降序作者升序作者降序发表日期升序发表日期降序 Cross-ancestry genome-wide association studies of brain imaging phenotypes 期刊论文  OAI收割 NATURE GENETICS, 2024, 页码: 31 作者:  Fu, Jilian;  Zhang, Quan;  Wang, Jianhua;  Wang, Meiyun;  Zhang, Bing   |  收藏  |  浏览/下载：24/0  |  提交时间：2024/06/29 Results of the phase IIa study to evaluate the efficacy and safety of rezivertinib (BPI-7711) for the first-line treatment of locally advanced or metastatic EGFR mutation from a phase I 期刊论文  OAI收割 BMC MEDICINE, 2023, 卷号: 21, 期号: 1 作者:  Yuankai Shi;  Jianying Zhou;  Yanqiu Zhao   |  收藏  |  浏览/下载：13/0  |  提交时间：2024/05/07 Efficacy and Safety of Recombinant Human-Mouse Chimeric Anti-CD20 Monoclonal Antibody (SCT400) Combined with CHOP in Patients with Treatment-Naive Diffuse Large B-Cell Lymphoma: A Multicenter, Randomized, Single-Blind, Parallel Active-Controlled, Phase III Study 期刊论文  OAI收割 BLOOD, 2021, 卷号: 138 作者:  Shi, Yuankai;  Zhang, Qing Yuan;  Hong, Xiaonan;  Wang, Zhen;  Gao, Yuhuan   |  收藏  |  浏览/下载：44/0  |  提交时间：2022/12/23 Safety, Clinical Activity, and Pharmacokinetics of Al flutinib (AST2818) in Patients With Advanced NSCLC With EGFR T790M Mutation 期刊论文  OAI收割 JOURNAL OF THORACIC ONCOLOGY, 2020, 卷号: 15, 期号: 6, 页码: 1015-1026 作者:  Shi, Yuankai;  Zhang, Shucai;  Hu, Xingsheng;  Feng, Jifeng;  Ma, Zhiyong   |  收藏  |  浏览/下载：102/0  |  提交时间：2020/12/24 Alflutinib  NSCLC  EGFR T790M mutation  Efficacy  Safety   Comprehensive lipid profiling of plasma in patients with benign breast tumor and breast cancer reveals novel biomarkers 期刊论文  OAI收割 analytical and bioanalytical chemistry, 2015, 卷号: 407, 期号: 17, 页码: 5065-5077 作者:  Yang, Li;  Cui, Xinge;  Zhang, Ningning;  Li, Min;  Bai, Yu 收藏  |  浏览/下载：43/0  |  提交时间：2015/11/17 Breast cancer  Benign breast tumor  Lipidomics  Biomarker  NP/RP 2DLC-MS   Efficacy and safety of iruplinalkib (WX-0593) in ALK -positive crizotinib-resistant advanced non-small cell lung cancer patients: a single-arm, multicenter phase II study (INTELLECT) 期刊论文  OAI收割 BMC MEDICINE, 卷号: 21, 期号: 1 作者:  Yuankai Shi;  Jianhua Chen;  Helong Zhang;  Zhihong Zhang;  Yiping Zhang   |  收藏  |  浏览/下载：5/0  |  提交时间：2024/05/07